Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FDA allows 23andMe to sell test for 3 mutations of breast cancer gene

      FDA allows 23andMe to sell test for 3 mutations of breast cancer gene

      Ruby Khatun Khatun7 March 2018 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected...
      FDA approves new dosing for Bristol-Myers Squibbs Opdivo

      FDA approves new dosing for Bristol-Myers Squibb's Opdivo

      Ruby Khatun Khatun7 March 2018 9:30 AM IST
      Bristol-Myers Squibb Co said the U.S. Food and Drug Administration had approved a four-week dosing schedule for its cancer drug, Opdivo.Opdivo with a...
      NPPA fixes prices of 12 formulations including Brufen Plus,Vitamin D3; check out details

      NPPA fixes prices of 12 formulations including Brufen Plus,Vitamin D3; check out details

      Ruby Khatun Khatun6 March 2018 3:41 PM IST
      New Delhi: National drug pricing regulator NPPA said it has fixed the retail/ceiling prices of 12 formulations including those used for the treatment...
      Aurobindo Pharmas unit gets 9 USFDA observations

      Aurobindo Pharma's unit gets 9 USFDA observations

      Ruby Khatun Khatun6 March 2018 3:40 PM IST
      NEW DELHI: Drug firm Aurobindo Pharma said the US health regulator has issued 9 observations after inspection of its unit 4 formulation facility in...
      To offset US slump, Torrent to trun to doemstic market

      To offset US slump, Torrent to trun to doemstic market

      Ruby Khatun Khatun6 March 2018 10:15 AM IST
      Mumbai: The Ahmedabad-based drug maker Torrent Pharmaceuticals is turning its attention to the domestic market along with increased focus on the South...
      LiveHealth raises Rs 7 crore in seed funding

      LiveHealth raises Rs 7 crore in seed funding

      Ruby Khatun Khatun6 March 2018 10:11 AM IST
      New Delhi: Nexus Venture Partners said it has invested USD 1.1 million (Rs 7 crore) in Pune-based LiveHealth, which digitizes diagnostic lab...
      Two jailed for attempting to smuggle ketamine to Singapore

      Two jailed for attempting to smuggle ketamine to Singapore

      Ruby Khatun Khatun6 March 2018 10:00 AM IST
      Coimbatore: A court here sentenced two men, including a CISF constable, to five years in jail for attempting to smuggle a narcotic substance ketamine,...
      Brands in India to be included in review for consumer health business: Pfizer

      Brands in India to be included in review for consumer health business: Pfizer

      Ruby Khatun Khatun6 March 2018 9:45 AM IST
      New Delhi: Drug firm Pfizer said Gelusil, Becosules and Corex brands in India will be included in the global strategic review of the consumer...
      Siemens eyes 4.65 billion euros in Healthineers IPO

      Siemens eyes 4.65 billion euros in Healthineers IPO

      Ruby Khatun Khatun6 March 2018 9:30 AM IST
      Berlin: Siemens said it plans to list its Healthineers medical unit on March 16, in an initial public offering that could net the group up to 4.65...
      US judge orders Pharma Bro to give up 7.36 million dollars

      US judge orders Pharma Bro to give up 7.36 million dollars

      Ruby Khatun Khatun6 March 2018 9:15 AM IST
      NEW YORK: Former drug company executive Martin Shkreli may have to give up a Picasso and a one-of-a-kind Wu-Tang Clan album, after a U.S. judge on...
      Refix ceiling price of Sun Pharma

      Refix ceiling price of Sun Pharma's ciprofloxacin 250mg, 500mg tablets: DoP tells NPPA

      Ruby Khatun Khatun5 March 2018 5:48 PM IST
      The Department of Pharmaceuticals (DoP) has given its decision in favour of Sun Pharma against the price fixing of ciprofloxacin 250mg and...
      PharmEasy raises approx Rs 196-crore in series-C round funding

      PharmEasy raises approx Rs 196-crore in series-C round funding

      Ruby Khatun Khatun5 March 2018 5:24 PM IST
      BENGALURU: Bessemer Venture Partners with participation from Orios Venture Partners, JM Financial, Manipal Education and Medical Group (MEMG) and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok